SC IV A. Membership of the European Pharmacopoeia Commission

In addition to the United Kingdom, the Member States party to the Convention on the Elaboration of a European Pharmacopoeia are as follows: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, The Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, The Former Yugoslav Republic of Macedonia, Turkey and Ukraine. The European Union is also party to the Convention.

Observers to the European Pharmacopoeia Commission at the time of publication are: Albania, Algeria, Argentina, Armenia, Australia, Azerbaijan, Belarus, Brazil, Canada, China, Georgia, India, Israel, Kazakhstan, Republic of Korea, Japan, Madagascar, Malaysia, Moldova, Morocco, Republic of Guinea, The Russian Federation, Senegal, Singapore, Syria, Tunisia, the United States of America, the Taiwan Food and Drug Administration (TFDA) of the Ministry of Health and Welfare and the World Health Organization.

The United Kingdom delegation to the European Pharmacopoeia Commission up to 31 December 2017 was as follows:

Dr S Atkinson

Professor A Davidson

Professor K Taylor

Alternate member of the United Kingdom delegation up to 31 December 2017 was as follows:

Dr R Horder

Mr J Pound

UK Membership of Groups of Experts of the European Pharmacopoeia Commission

The United Kingdom is represented in all of the major Groups of Experts of the European Pharmacopoeia Commission. The UK membership of the Groups on 31 December 2017 is as listed in the table below.

UK Membership of Working Parties of the European Pharmacopoeia Commission

The UK membership of the Working Parties on 31 December 2017 is as follows.